Intracranial Bleeding in a Female Hemophilia Patient: Molecular Analysis of the Factor 8 Gene and Determination of a Novel Mutation

Abstract

Hemophilia A is rarely seen in female patients due to skewed inactivation of the X chromosome leading to inactivation of the wild-type X chromosome, anomalies like Turner syndrome, or translocations, as well as homozygous/compound heterozygous mutations for hemophilia A [1,2,3,4,5]. The clinical situation of our patient as she was admitted with epidural hematoma requiring surgical intervention and the fact that the family did not apply for prenatal diagnosis before birth point out the importance of prenatal diagnosis in regions where consanguineous marriage is common. Conflict of Interest: The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.

Headnote

Keywords: Hemophilia, Intracranial bleeding, Female

Anahtar Sözcükler: Hemofili, İntrakraniyal kanama, Kız cinsiyet

To the Editor,

An 11-month-old female patient was admitted to the emergency department with right occipital fracture and epidural hematoma. The father had severe hemophilia A and the parents were cousins. Laboratory tests revealed normal complete blood count and prolonged activated partial thromboplastin time. Mixing test results were normalized after mixing with normal plasma. After plasma samples were collected for further diagnostic tests, fresh frozen plasma and dexamethasone were administered. The factor VIII level was 0.1%, 35%, and 0.5% for the patient, mother, and father, respectively. The patient's von Willebrand factor (VWF) level was 128 IU/mL, VWF:Ricof was 110 IU/mL, collagen ADP was 110 (reference: 71-118) s, and collagen epinephrine was 98 (reference: 85-165) s. Intron 22 inversion was investigated with the IS-PCR method and was found to be normal. Whole-genome analysis including all exonic regions of the F8 gene (NM_000132.3) was conducted and the homozygous c.608T>C (L203P) mutation was found. This mutation was not previously reported. As this variant was not reported in any exome databases (ExAC, EVS) and as it was shown to be the cause of the disease in at least three in silico protein modeling programs, the mutation was considered as a novel mutation causing hemophilia A ("probably damaging" with 0.987 PolyPhen2 score, "disease causing" with 0.999 MutationTaster score, and "damaging" with 0 SIFT score). The mutation was also confirmed by Sanger sequencing (Figure 1). Plasma-derived FVIII at 2x500 IU/day was administered for 14 days followed by 300 IU/week prophylaxis. Inhibitor screening at the 5th and 10th exposure days was negative.

Hemophilia A is rarely seen in female patients due to skewed inactivation of the X chromosome leading to inactivation of the wild-type X chromosome, anomalies like Turner syndrome, or translocations, as well as homozygous/compound heterozygous mutations for hemophilia A [1,2,3,4,5]. The karyotype analysis of our patient revealed 46,XX. The patient and the father were hemizygous and mother was heterozygous for the c.608T>C (L203P) mutation (Figure 2). The clinical situation of our patient as she was admitted with epidural hematoma requiring surgical intervention and the fact that the family did not apply for prenatal diagnosis before birth point out the importance of prenatal diagnosis in regions where consanguineous marriage is common.

Conflict of Interest: The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.

Sidebar

Address Department for Correspondence/Yazışma of Pediatric Hematology, Ankara, Adresi: Turkey Fatma Burcu BELEN, M.D., Başkent University Faculty of Medicine,

Phone : [phone]

E-mail : [email protected] ORCID-ID: orcid.org/0000-0002-9278-6703

Received/Geliş tarihi: October 26, 2017

Accepted/Kabul tarihi: January 26, 2018

DOI: 10.4274/tjh.2017.0385

References

References

1. Knobe KE, Sjörin MJ, Soller MJ,Liljebjörn H, Ljung RCA. Female hemophilia A: two unusual cases caused by skewed inactivation. Haemophilia 2008;14:846-848.

2. Renault NK, Dyack S, Dobson MJ, Costa T, Lam WL, Greer WL. Heritable skewed X-chromosome inactivation leads to haemophilia A expression in heterozygous females. Eur J Hum Genet 2007;15:628-637.

3. Chuansumrit A, Sasanakul W, Goodeve A, Treratvirapong T, Parinayok R, Pintadit P, Hathirat P. Inversion of intron 22 of the factor VIII gene in a girl with severe hemophilia A and Turner's syndrome. Thromb Haemost 1999;82:1379.

4. David D, Morais S, Ventura C, Campos M. Female haemophiliac homozygous for factor VIII intron 22 inversion mutation, with transcriptional inactivation of one of the FVIII alleles. Haemophilia 2003;9:125-130.

5. Pavlova A, Brondke H, Müsebeck J, Pollmann H, Srivastava A, Oldenburg J. Molecular mechanisms underlying hemophilia A phenotype in seven females. J Thromb Haemost 2009;7:976-982.